Trifecta Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20
Closed -$3.14K 285
2025
Q3
$3.14K Hold
20
﹤0.01% 297
2025
Q2
$3.36K Hold
20
﹤0.01% 293
2025
Q1
$2.76K Hold
20
﹤0.01% 281
2024
Q4
$2.37K Hold
20
﹤0.01% 286
2024
Q3
$2.21K Hold
20
﹤0.01% 300
2024
Q2
$1.97K Hold
20
﹤0.01% 315
2024
Q1
$2.24K Hold
20
﹤0.01% 297
2023
Q4
$2.02K Hold
20
﹤0.01% 328
2023
Q3
$1.74K Hold
20
﹤0.01% 323
2023
Q2
$1.89K Hold
20
﹤0.01% 315
2023
Q1
$1.51K Hold
20
﹤0.01% 335
2022
Q4
$1.54K Buy
+20
New +$1.52K ﹤0.01% 344

Other funds holding CAH

Trifecta Capital Advisors's CAH Position: Q4 2025 in Review

Trifecta Capital Advisors sold out of Cardinal Health (CAH) in Q4 2025, closing a stake of 20 shares — an estimated $3.14K sold.

Trifecta Capital Advisors first reported a position in CAH in Q4 2022 and held it in 12 quarters. The position peaked at $3.36K in Q2 2025. 1,406 funds tracked by Wall St. Rank hold CAH as of Q4 2025.

  • Trifecta Capital Advisors reported no remaining Cardinal Health position as of Q4 2025 after selling out during the quarter.
  • Trifecta Capital Advisors sold 20 Cardinal Health shares in Q4 2025, an estimated $3.14K.
  • Trifecta Capital Advisors first reported a position in Cardinal Health in Q4 2022 and held it in 12 quarters.
  • Trifecta Capital Advisors's Cardinal Health position peaked at $3.36K in Q2 2025.
  • 1,406 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2025.

Based on Trifecta Capital Advisors's 13F filing for Q4 2025, filed 30 Jan 2026.